Press release
Intravenous Immunoglobulin Market: Advancements, Applications, and Emerging Opportunities Till 2031 | CSL Behring LLC, Grifols, S.A., Octapharma AG, Kedrion S.p.A., Biotest AG
Advancements in Production and Formulations: The IVIG market has seen advancements in production techniques and the development of newer formulations, which have improved the safety, efficacy, and convenience of IVIG administration.
UPDATE AVAILABLE ON-DEMAND: https://www.alliedmarketresearch.com/on-demand-updates/A00235
Competitive Landscape: Several pharmaceutical companies and biotechnology firms are involved in the production and distribution of IVIG products, leading to a competitive market environment.
Pricing and Reimbursement Challenges: The high cost of IVIG treatment and complexities in reimbursement processes have posed challenges for patients and healthcare providers, potentially affecting market growth.
Market Segmentation:
Indication:
a. Primary Immunodeficiency Diseases (PIDD): Includes conditions like common variable immunodeficiency (CVID), X-linked agammaglobulinemia (XLA), and others.
b. Neurological Disorders: Guillain-Barré syndrome (GBS), chronic inflammatory demyelinating polyneuropathy (CIDP), myasthenia gravis, etc.
c. Autoimmune Diseases: Rheumatoid arthritis, systemic lupus erythematosus (SLE), immune thrombocytopenic purpura (ITP), etc.
d. Secondary Immunodeficiency: Immunodeficiency disorders that are acquired as a result of other conditions or treatments.
e. Other Off-Label Uses: IVIG may be used for conditions not officially approved, but where its efficacy has been observed.
Formulation:
a. Liquid IVIG: Traditional liquid formulations administered through intravenous infusion.
b. Lyophilized IVIG: Freeze-dried formulations that require reconstitution before administration.
End-user:
a. Hospitals: Large hospitals and medical centers where IVIG treatment is provided to patients.
b. Clinics and Ambulatory Surgical Centers (ASCs): Outpatient settings that offer IVIG therapy.
c. Home Care Settings: IVIG administered at the patient's home by healthcare professionals or trained caregivers.
Route of Administration:
a. Intravenous (IV) Infusion: IVIG is directly infused into the bloodstream through a vein.
b. Subcutaneous (SC) Injection: IVIG can also be administered subcutaneously, though this route is less common.
Distribution Channel:
a. Hospital Pharmacies
b. Retail Pharmacies
c. Online Pharmacies
Geography:
The IVIG market can be segmented based on regions, such as North America, Europe, Asia-Pacific, Latin America, and the Middle East & Africa.
Request for Customization - https://www.alliedmarketresearch.com/request-for-customization/325
Competitive Landscape:
CSL Behring LLC
Grifols, S.A.
Takeda Pharmaceutical Company Limited
Octapharma AG
Kedrion S.p.A.
Biotest AG
China Biologic Products Holdings, Inc.
Shire (acquired by Takeda Pharmaceutical Company)
LFB Group
Sanquin (Blood Supply Foundation)
Procure Complete Report at 20% Discount (258 Pages)
https://www.alliedmarketresearch.com/purchase-enquiry/325
Related Reports :
Patient Simulator Market https://www.alliedmarketresearch.com/patient-simulator-market-A11667
Nucleic Acid Therapeutics Market https://www.alliedmarketresearch.com/nucleic-acid-therapeutics-market-A17089
Fluid Management Devices Market https://www.alliedmarketresearch.com/fluid-management-devices-market
Pediatric Neurology Device Market https://www.alliedmarketresearch.com/pediatric-neurology-device-market-A11670
Contact:
David Correa
5933 NE Win Sivers Drive
#205, Portland, OR 97220
United States
USA/Canada (Toll Free):
+1-800-792-5285, +1-503-894-6022
UK: +44-845-528-1300
Hong Kong: +852-301-84916
India (Pune): +91-20-66346060
Fax: +1(855)550-5975
help@alliedmarketresearch.com
Web: www.alliedmarketresearch.com
Allied Market Research Blog: https://blog.alliedmarketresearch.com
About Allied Market Research:
Allied Market Research (AMR) is a full-service market research and business-consulting wing of Allied Analytics LLP based in Portland, Oregon. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of "Market Research Reports" and "Business Intelligence Solutions." AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domains. AMR offers its services across 11 industry verticals including Life Sciences, Consumer Goods, Materials & Chemicals, Construction & Manufacturing, Food & Beverages, Energy & Power, Semiconductor & Electronics, Automotive & Transportation, ICT & Media, Aerospace & Defense, and BFSI.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Intravenous Immunoglobulin Market: Advancements, Applications, and Emerging Opportunities Till 2031 | CSL Behring LLC, Grifols, S.A., Octapharma AG, Kedrion S.p.A., Biotest AG here
News-ID: 3229054 • Views: …
More Releases from Allied Market Research
Liability Insurance Market Global Opportunity Analysis and Industry Forecast, 20 …
Allied Market Research published a report, titled, "Liability Insurance Market by Coverage Type (General Liability Insurance, Professional Liability Insurance, Insurance for Directors and Officers), by Enterprise Size (Medium-sized Enterprises, Large Enterprises, Small Enterprises), by Application (Commercial, Personal): Global Opportunity Analysis and Industry Forecast, 2021-2031." According to the report, the global liability insurance industry generated $252.34 billion in 2021, and is expected to reach $432.81 billion by 2031, witnessing a CAGR…
Umbrella Insurance Market to Hit $170.7 Billion by 2031, Growing at 9.2% CAGR
Umbrella insurance is a form of casualty insurance designed to shield individuals from significant liability claims that surpass the coverage limits of their primary commercial general liability, business auto, and other business insurance policies. It offers a cost-effective solution for significantly increasing liability limits, providing added protection against catastrophic claims in today's unpredictable environment.
Request Sample Pages Now: https://www.alliedmarketresearch.com/request-sample/15130
Allied Market Research published a report, titled, "Umbrella Insurance Market Size by Coverage…
Bancassurance Market to Reach $1.8 Trillion by 2031, Growing at 7.4% CAGR
Allied Market Research published a report, titled, "Bancassurance Market by Insurance Type (Life Insurance, Non-Life Insurance), by Model Type (Pure Distributor Model, Strategic Alliance Model, Joint Venture Model, Financial Holding, Others), by End User (Personal, Business): Global Opportunity Analysis and Industry Forecast, 2021-2031" According to the report, the global bancassurance industry generated $901.5 billion in 2021, and is estimated to reach $1.8 trillion by 2031, witnessing a CAGR of 7.4%…
Lendtech Market to Reach $61.9 Billion by 2031, Growing at 23.2% CAGR
Allied Market Research published a report, titled, "LendTech Market by Component (Solution and Services), Deployment Mode (On-Premises and Cloud), Type (Consumer Lending and Business Lending), Organization Size (Large Enterprises and Small and Medium-sized Enterprises), and End User (Banks, Insurance Companies, Credit Unions and NBFCs) And Region (North America, Europe, Asia-Pacific, and LAMEA): Global Opportunity Analysis and Industry Forecast, 2022-2031" According to the report, the global lendtech industry generated $8 billion…
More Releases for IVIG
IVIg Powder Market 2022-2028 Global Key Manufacturers' Analysis Review
The "Global IVIg Powder Market Analysis to 2028" is a specialized and in-depth study of the healthcare industry with a special focus on the global market trend analysis. The report aims to provide an overview of the IVIg Powder market with detailed market segmentation by drug class and distribution channel. The report provides key statistics on the market status of the leading IVIg Powder market players and offers key trends…
Intravenous Immunoglobulin (IVIG) Market Size, Share | Industry Report 2026
The global Intravenous Immunoglobulin Market was valued at $13.7Billion in 2018 and is forecast to grow at a modestxx.3 % CAGR between 2018 and 2026, culminating in 2026 global sales of $16.7Billion.
Intravenous Immunoglobulin (IVIG) is a solution of highly purified immunoglobulin G, derived from large human plasma that contains antibodies against a broad spectrum of bacterial and viral agents. Intravenous immunoglobulin of properties isa composition that addition of albumin,…
Intravenous Immunoglobulin (IVIG) Market: Rising Prevalence of Neurological Dise …
This report on the global intravenous immunoglobulin (IVIG) market analyzes the current and future prospects of the market. The report comprises an elaborate executive summary, including a market snapshot that provides overall information of various segments and sub-segments. The research is a combination of primary and secondary research. Primary research formed the bulk of our research efforts along with information collected from telephonic interviews and interactions via e-mails.
Secondary research…
Intravenous Immunoglobulin (IVIG) Market: Rising Production of IVIG Products are …
The global market for intravenous immunoglobulin (IVIG) products and therapies is heading in a positive direction due to several innovative techniques and advantages it offers to clinicians worldwide. The market is expected to expand at a healthy pace in the near future. Factors that will support market’s growth include technological improvements in the methods used for production and purification of IVIG products and an improving health care infrastructure across the…
Global Intravenous Immunoglobulin (IVIg) Market
The Intravenous Immunoglobulin Market report provides in-depth analysis of parent market trends, macro-economic indicators and governing factors along with market attractiveness as per segments. The report also maps the qualitative impact of various market factors on market segments and geographies.
The term “immunoglobulin” refers to the breakdown of blood plasma that contains antibody. IVIg is a blood product which is administered intravenously. It contains polyvalent IgG antibodies which are extracted from…
Global Intravenous Immunoglobulin (IVIG) Market: Rising Patient Pool of Neurolog …
The global intravenous immunoglobulin (IVIG) market is largely consolidated, with top four players: Grifols S.A., CSL Behring LLC, Baxalta Incorporated, and Octapharma AG, accounting for over 70% of the overall market in 2015. Grifols S.A. accounted for the dominant share of 23.0%, chiefly on account of the company’s strong geographic penetration.
Oligopoly in the market has led to intense competition among top players and has compelled companies to take course of…
